Elysium's Creatine+ Combines Three Ingredients to Target Muscle Aging and Recovery
Elysium Health launches Creatine+, blending creatine, HMB, and pomegranate polyphenols to support strength, recovery, and healthy aging.
Summary
Elysium Health has launched Creatine+, a supplement combining creatine monohydrate, HMB, and pomegranate-derived polyphenols standardized to urolithin A precursors. Developed with input from Stanford longevity researcher Dr. Michael Fredericson, the product targets muscle preservation, recovery, and mitochondrial health in aging adults. Unlike traditional sports supplements focused purely on performance, Creatine+ is positioned as a longevity tool. Muscle health is now widely recognized as a key predictor of healthy aging, influencing mobility, metabolic health, and independence. By age 80, muscle mass can decline by roughly 30%, making proactive muscle support increasingly important for anyone focused on long-term physical function and quality of life.
Detailed Summary
Muscle health has quietly become one of the most important frontiers in longevity science. While futuristic therapies grab headlines, researchers increasingly point to skeletal muscle as a foundational marker of healthy aging — one that influences metabolism, mobility, resilience, and even cognitive function. It is in this context that Elysium Health has launched Creatine+, a supplement formulated specifically with aging adults in mind rather than competitive athletes.
The product combines three ingredients: creatine monohydrate, HMB (beta-hydroxy beta-methylbutyrate), and pomegranate polyphenols standardized to urolithin A precursors. Creatine is one of the most studied supplements available and supports lean muscle mass and strength. HMB is included to reduce muscle protein breakdown and accelerate recovery. The pomegranate-derived compounds are intended to support mitochondrial health — critical because mitochondrial efficiency declines with age, reducing the energy available to muscles and tissues.
The formulation was developed with advisement from Dr. Michael Fredericson, co-director of the Stanford Center on Longevity and a member of Elysium's Scientific Advisory Board. Fredericson noted that creatine has become one of his preferred supplements for maintaining lean body mass during aging, particularly when paired with resistance training. He also highlighted that women face distinct muscle physiology changes with age, making targeted nutritional support especially relevant.
The launch reflects a broader shift in how the longevity sector thinks about physical function. Rather than chasing lifespan extension alone, the field is increasingly focused on preserving the strength and independence that determine quality of life in later decades. By age 80, muscle mass declines by approximately 30%, with strength and power dropping even further.
A key caveat: this article is a product launch announcement, not a peer-reviewed clinical trial. The ingredient combination has not been tested as a unified formula in published human studies. Individual components have established evidence bases, but synergistic effects of this specific blend remain to be validated independently.
Key Findings
- Creatine+ combines creatine monohydrate, HMB, and urolithin A precursors to support muscle preservation and mitochondrial health.
- Muscle mass declines roughly 30% by age 80, making proactive supplementation and resistance training critical for healthy aging.
- HMB targets muscle protein breakdown and recovery, complementing creatine's well-established strength and lean mass benefits.
- Pomegranate polyphenols standardized to urolithin A precursors aim to support mitochondrial efficiency, which declines with age.
- Stanford longevity researcher Dr. Fredericson specifically recommends creatine for women facing age-related muscle physiology changes.
Methodology
This is a product launch news report published by Longevity.Technology, a trade publication covering the longevity industry. The article is based on a press announcement from Elysium Health and quotes from a Scientific Advisory Board member, not independent peer-reviewed research. No clinical trial data specific to the Creatine+ formulation is cited.
Study Limitations
This article is a commercial product announcement, not a peer-reviewed study, and should not be treated as clinical evidence for the specific formulation. The synergistic effects of creatine, HMB, and pomegranate polyphenols together have not been independently validated in published human trials. Readers should consult primary literature on each ingredient separately and discuss supplementation with a healthcare provider.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.